menu
    • menu

    Company profile for Alpha Cognition

    NEW Drugs in Dev: 4
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Alpha Cognition Inc. (ACI) is engaged in neurological disease research and has developed programs in Alzheimer's Disease and amyotrophic lateral sclerosis (ALS). Alpha-1062 is a patented new chemical entity that has shown efficacy in preclinical and recently completed human clinical trials. It is being developed as a new generation acetylcholine esterase inhibitor (AChEI) with minimal gastrointestinal side effects and new r...
    Alpha Cognition Inc. (ACI) is engaged in neurological disease research and has developed programs in Alzheimer's Disease and amyotrophic lateral sclerosis (ALS). Alpha-1062 is a patented new chemical entity that has shown efficacy in preclinical and recently completed human clinical trials. It is being developed as a new generation acetylcholine esterase inhibitor (AChEI) with minimal gastrointestinal side effects and new routes of administration.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Alpha CognitionCanada Flag
    Country
    Country
    Canada
    Address
    Address
    439 Helmcken Street, Vancouver, B.C. V6B 2E6
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.alphacognition.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    AMWC Asia-TDAC

    AMWC Asia-TDAC

    Not Confirmed

    envelop Contact Supplier

    AMWC Asia-TDAC

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Alpha Cognition Reports Inducement Grants Under Nasdaq 5635(c)(4)
    Alpha Cognition Reports Inducement Grants Under Nasdaq 5635(c)(4)

    15 Apr 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260415562909/en/Alpha-Cognition-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635c4

    BUSINESSWIRE
    15 Apr 2026
    Share Share
    Alpha Cognition Patents ALPHA-1062 for Brain Injury Treatment
    Alpha Cognition Patents ALPHA-1062 for Brain Injury Treatment

    01 Apr 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260401736131/en/Alpha-Cognition-Receives-Issued-U.S.-Patent-for-ALPHA-1062-for-Treatment-of-Traumatic-Brain-Injury

    BUSINESSWIRE
    01 Apr 2026
    Share Share
    Alpha Cognition Reports FY25 Results, Operational Update
    Alpha Cognition Reports FY25 Results, Operational Update

    26 Mar 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260326475641/en/Alpha-Cognition-Inc.-Reports-Fiscal-2025-Financial-Results-and-Provides-Operational-Update

    BUSINESSWIRE
    26 Mar 2026
    Share Share
    Alpha Cognition to Report Q4 and Full Year 2025 Financial Results
    Alpha Cognition to Report Q4 and Full Year 2025 Financial Results

    13 Mar 2026

    // BUSSINESSWIRE

    https://www.businesswire.com/news/home/20260313845487/en/Alpha-Cognition-Nasdaq-ACOG-to-Report-Fourth-Quarter-and-Full-Year-2025-Financial-Results-and-Provide-Business-Update-on-Thursday-March-26-2026

    BUSSINESSWIRE
    13 Mar 2026
    Share Share
    Alpha Cognition To Present New Clinical On ZUNVEYL
    Alpha Cognition To Present New Clinical On ZUNVEYL

    10 Mar 2026

    // BUSSINESSWIRE

    https://www.businesswire.com/news/home/20260310594648/en/Alpha-Cognition-to-Present-New-Clinical-on-ZUNVEYL-Benzgalantamine-at-Multiple-Upcoming-Alzheimers-Association-International-Conferences

    BUSSINESSWIRE
    10 Mar 2026
    Share Share
    Alpha Cognition Initiates BEACON Real-World Effectiveness Study
    Alpha Cognition Initiates BEACON Real-World Effectiveness Study

    25 Feb 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260225883160/en/Alpha-Cognition-Announces-First-Patient-Enrolled-in-BEACON-Real-World-Effectiveness-Study

    BUSINESSWIRE
    25 Feb 2026
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search